US stocks surge to record highs
The S&P 500 notched up eight straight record closes in a row recently, while the small-cap Russell 2000 index saw its first record close since March.
Central banks may have made bond markets wobble, but stocks are still going from strength to strength, says Nicholas Megaw in the Financial Times. Strong US third-quarter earnings have put worries about inflation on the back burner. Profits at S&P 500 firms rose by about 40% year-on-year between July and September. Sales increased by roughly a fifth.
“Large US companies are broadly managing to weather the surge in the prices of raw materials, supply chain bottlenecks and shortages in the labour market,” say Joe Rennison and Colby Smith in the same paper. Corporate profit margins have fallen back slightly, but by much less than analysts had been expecting.
Major US stock benchmarks continue to make new record highs, says Mark DeCambre on MarketWatch. The S&P 500 notched up eight straight record closes through Monday this week, its longest streak of all-time peaks since 1997. Smaller companies have also joined the party: the small-cap Russell 2000 index has just had its first record close since March.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
“It doesn’t get any better than this for the stockmarket,” says Ben Levisohn in Barron’s. A “stellar” jobs report – the US economy added 531,000 jobs last month – only adds to a picture of an American economy regaining its vigour after a sluggish summer. There is growing hope that new antiviral treatments from Merck and Pfizer will soon draw a line under the pandemic era.
To top it all, Congress has finally approved a $1.2trn infrastructure bill after months of wrangling. Equities fell by 5% in September, sparking talk of a correction (defined as a stockmarket decline of 10%). Instead, equities have since rallied by 7%. Is that a reason to sell? With the bulls out in force, probably not. “Bet on a rip-roaring rally into the end of the year.”
-
Coventry Building Society bids £780m for Co-operative Bank - what could it mean for customers?
Coventry Building Society has put in an offer of £780 million to buy Co-operative Bank. When will the potential deal happen and what could it mean for customers?
By Vaishali Varu Published
-
Review: Three magnificent Beachcomber resorts in Mauritius
MoneyWeek Travel Ruth Emery explores the Indian Ocean island from Beachcomber resorts Shandrani, Trou aux Biches and Paradis
By Ruth Emery Published
-
The industry at the heart of global technology
The semiconductor industry powers key trends such as artificial intelligence, says Rupert Hargreaves
By Rupert Hargreaves Published
-
Three emerging Asian markets to invest in
Professional investor Chetan Sehgal of Templeton Emerging Markets Investment Trust tells us where he’d put his money
By Chetan Sehgal Published
-
What to consider before investing in small-cap indexes
Small-cap index trackers show why your choice of benchmark can make a large difference to long-term returns
By Cris Sholto Heaton Published
-
Why space investments are the way to go for investors
Space investments will change our world beyond recognition, UK investors should take note
By Merryn Somerset Webb Published
-
Time to tap into Africa’s mobile money boom
Favourable demographics have put Africa on the path to growth when it comes to mobile money and digital banking
By Rupert Hargreaves Published
-
M&S is back in fashion: but how long can this success last?
M&S has exceeded expectations in the past few years, but can it keep up the momentum?
By Rupert Hargreaves Published
-
The end of China’s boom
Like the US, China too got fat on fake money. Now, China's doom is not far away.
By Bill Bonner Published
-
Magic mushrooms — an investment boom or doom?
Investing in these promising medical developments might see you embark on the trip of a lifetime.
By Bruce Packard Published